Shopping Cart
Remove All
Your shopping cart is currently empty
Bedinvetmab (Synonyms: ZTS-00508841, ZTS00508841)
Catalog No. T76813 Copy Product Info
Purity: 95%
🥰Excellent
Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) engineered to target nerve growth factor (NGF). Bedinvetmab prevents NGF from binding its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR). Bedinvetmab is primarily utilized in osteoarthritis research, where it is studied for its ability to manage pain in canine models.
Bedinvetmab
Copy Product Info🥰Excellent
Catalog No. T76813
Synonyms ZTS-00508841, ZTS00508841
Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) engineered to target nerve growth factor (NGF). Bedinvetmab prevents NGF from binding its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR). Bedinvetmab is primarily utilized in osteoarthritis research, where it is studied for its ability to manage pain in canine models.
Bedinvetmab
Cas No. 2171034-69-6
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $647 | - | In Stock | |
| 10 mg | $987 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:98.0% (SDS-PAGE); 96.5% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) engineered to target nerve growth factor (NGF). Bedinvetmab prevents NGF from binding its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR). Bedinvetmab is primarily utilized in osteoarthritis research, where it is studied for its ability to manage pain in canine models. |
| In vivo | Bedinvetmab (0.5-1 mg/kg, subcutaneous injection, every 28 days) can effectively alleviate pain associated with canine osteoarthritis [1]. Bedinvetmab (1 mg/kg, subcutaneous injection, monthly; 3-fold and 10-fold doses) demonstrated good tolerability when co-administered with Carprofen in normal laboratory beagle dogs [2]. |
| Synonyms | ZTS-00508841, ZTS00508841 |
| Reactivity | Canlupfam |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | NGF |
| Molecular Weight | 145.61 kDa |
| Cas No. | 2171034-69-6 |
| Isotype | IgG2 lambda |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Bedinvetmab | purchase Bedinvetmab | Bedinvetmab cost | order Bedinvetmab | Bedinvetmab in vivo | Bedinvetmab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.